first_imgPolitics GET STARTED Washington Correspondent Lev Facher covers the politics of health and life sciences. @sheridan_kate Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. First 30 days free. GET STARTED Log In | Learn More Ned Sharpless (left), joined by his wife, Julie Sharpless, is sworn in as director of the National Cancer Institute. NIH What is it? What’s included? By Lev Facher and Kate Sheridan March 14, 2019 Reprints About the Authors Reprints @levfacher center_img WASHINGTON — Almost immediately after beginning his Bethesda, Md., day job as the nation’s top cancer researcher, Ned Sharpless built a roughly 7-mile detour into his weekly routine: a sojourn to the Food and Drug Administration campus for a pickup basketball game.Whether or not the networking was intentional, Sharpless will soon be spending far more time with the FDA oncologists who once broke his finger. When Scott Gottlieb steps down after a nearly two-year tenure next month, Sharpless will take the helm of that agency, at least in the short term. Lev Facher A believer in biotech and big data: How Ned Sharpless vaulted to the top of the FDA [email protected] Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. General Assignment Reporter Kate covers biotech startups and the venture capital firms that back them. [email protected] Kate Sheridan Tags cancerCongressgovernment agenciesSTAT+White Houselast_img